These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3155391)

  • 1. [Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
    Serclová L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(5):649-55. PubMed ID: 3155391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of short-term and long-term (5 years) administration of a new preparation for the treatment of arterial hypertension].
    Bonomini V; Vangelista A; Fatone F
    G Clin Med; 1976; 57(1-2):46-65. PubMed ID: 828115
    [No Abstract]   [Full Text] [Related]  

  • 4. Isometheptene compound in the treatment of vascular headache.
    Behan PO
    Practitioner; 1978 Dec; 221(1326):937-9. PubMed ID: 372936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atropine preparations in the treatment of Horton's headache].
    Split W; Szmidt M
    Wiad Lek; 1984 Sep; 37(18):1417-20. PubMed ID: 6397917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Horton's headache with small doses of pilocarpine and carbamazepine].
    Goncikowska M
    Wiad Lek; 1984 Jul; 37(14):1093-5. PubMed ID: 6393589
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 8. [1-second value and oscillatory airway resistance in the evaluation of the effectiveness of beta-adrenergic agents under general practice conditions].
    Kropp R; Aurich R
    Prax Klin Pneumol; 1983 Nov; 37(11):1178-83. PubMed ID: 6361723
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of antigen-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Kuhn GJ; Weliky I; Santiago SM; Klaustermeyer WB
    Ann Allergy; 1981 Apr; 46(4):193-6. PubMed ID: 7011113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with using sinepress in hypertension].
    Orlov VM; Ivashchuk AG; Troshina EV; Iartsev SS; Gorokhovskaia GN
    Klin Med (Mosk); 1987 Apr; 65(4):30-1. PubMed ID: 3298841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind study of tiapride and placebo in patients with subcontinuous essential headache].
    Cerbo R; Casacchia M; Boni B; Corona R; Papola S; de Lena C
    Riv Neurol; 1982; 52(1):51-64. PubMed ID: 7046024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Crystepin T (Trimecryton). Multi-center evaluation of a anti-hypertensive agent containing a beta blocker].
    Mayer O; Cepelák V; Cícha Z; Kokaisl V; Mádle A; Mazanec J; Moses K; Vácha J
    Cas Lek Cesk; 1983 Jul; 122(29):906-12. PubMed ID: 6137281
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
    Bagatin J; Rumboldt Z; Jurisić M; Vujić D
    Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nebetol in the treatment of bronchial asthma and chronic obstructive bronchitis].
    Popovac D; Spasić P; Vukcević G
    Plucne Bolesti; 1985; 37(1-2):106-9. PubMed ID: 3906721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dihydroergocristine methanesulfonate: treatment of a severe case of perypheral ischemia induced by ergotamine tartrate].
    Setti M; Nespoli M; Losapio GM
    Angiologia; 1978; 30(3):98-102. PubMed ID: 207203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Theophylline in allergic bronchial asthma (author's transl)].
    Kügler D; Wettengel R
    Prax Klin Pneumol; 1982 Jan; 36(1):27-32. PubMed ID: 7048279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.